BETA

8 Amendments of Pierrette HERZBERGER-FOFANA related to 2023/2075(INI)

Amendment 30 #
Draft opinion
Recital A a (new)
Aa. whereas according to the World Health Organisation, climate change, air pollution and non-communicable diseases represent some of the most serious threats to global health;
2023/07/24
Committee: DEVE
Amendment 36 #
Draft opinion
Recital A b (new)
Ab. whereas the COVID-19 pandemic has exposed insufficient investment in the Health Care Workforce and shown how unprepared health systems were to respond to a global health crisis;
2023/07/24
Committee: DEVE
Amendment 39 #
Draft opinion
Recital A c (new)
Ac. whereas the WTO Doha Ministerial Conference of 2001 recognized the gravity of public health problems affecting many developing and least-developed countries, especially those resulting from HIV/AIDS, tuberculosis, malaria and other epidemics; whereas the Declaration on the TRIPS Agreement and Public Health (November 2001) clarifies that the TRIPS Agreement does not and should not prevent members from taking measures to protect public health; whereas the recognition of TRIPS flexibilities include inter alia that WTO Members have the right to grant compulsory licences and the right to determine what constitutes a national emergency; whereas according to WIPO, developing countries face constraints in making full use of TRIPS flexibilities;
2023/07/24
Committee: DEVE
Amendment 43 #
Draft opinion
Recital A d (new)
Ad. whereas the Agreement on Trade Related Investment Measures (TRIMS) and other investment rules, which are part of the Free Trade Agreements (FTAs), also compromise the efforts of many developing countries to achieve self- sufficiency in manufacturing of medical products by making the application of many local production stimulation tools like local content rule, export obligation, etc. as illegal;
2023/07/24
Committee: DEVE
Amendment 54 #
Draft opinion
Paragraph 1
1. Notes the surge in post-acute infection syndromes (PAIS) following COVID-19 infections; recalls that PAIS also occur following other bacterial, viral and parasitic infections, including mononucleosis, Lyme disease, Ebola, polio and influenza; recalls that the pathogenesis of PAIS is linked to chronic fatigue syndrome (ME/CFS), in the context of 65 million people suffering from long COVID to date, as well as reinfection pressure and upcoming pandemics; is concerned that the global health strategy addresses neither the post-acute sequelae of SARS-CoV-2 nor PAIS in general; recalls that many countries, especially those on the African continent, are still having major difficulties in accessing the health technologies used to fight not only the coronavirus but also other diseases; emphasises that the universal access to health depends among others on the ability of developing countries to build up their own production capacities and develop local know-how; in this respect, stresses that Intellectual Property Rights undoubtedly constitute a barrier to access to vaccines; urges the EU to support developing countries, in particular LDCs, in the effective implementation of flexibilities for the protection of public health provided for in TRIPs agreements, notably compulsory licencing and parallel import; calls for the EU, with a view to lessons learned from the pandemic, to make PAIS a priority and to develop an EU strategy for PAIS, comparable to Europe’s beating cancer plan and the EU strategy on mental health, and to extend the PAIS strategy to global health security, including in the implementation of the global health strategy;
2023/07/24
Committee: DEVE
Amendment 60 #
Draft opinion
Paragraph 2
2. Notes that guiding principle 2 of the global health strategy aims to ensure that innovative vaccines, treatments and diagnostics for new, prevalent or neglected infectious and non-communicable diseases are developed and used, including through funding from Horizon Europe and the EU- Africa Global Health European and Developing Countries Clinical Trials Partnership (EDCTP3) for research, capacity building and strengthening the regulatory environment in sub-Saharan Africa; calls for Team Europe to implement this approach, with a focus on non-communicable diseases. calls on the EU to support investment in health education and skills in developing countries, as well as regional cooperation, such as the African Continental Free Trade Area (AfCFTA) which have the potential advantages of establishing regional value chains to enable small economies in the region to collectively build the productive capability;
2023/07/24
Committee: DEVE
Amendment 63 #
Draft opinion
Paragraph 2 a (new)
2a. Recalls that health is a prerequisite for human development, which implies mobilizing additional public funds to guarantee Universal Health Coverage; stresses that the delivering of “horizontal health” through an holistic and rights-based approach entails i.a. to fully address the multidimensional nature of health (with close links to gender, food security and nutrition, water and sanitation, education and poverty), along the line of “One Health” approach;
2023/07/24
Committee: DEVE
Amendment 71 #
Draft opinion
Paragraph 2 b (new)
2b. Notes with deep concern that pollutants in the environment have a massive impact on global health, especially for low- and middle-income countries (LMICs); calls on the EU to assist developing countries, notably the LMICs and LDCs, to prioritize disease prevention, through investment in the management of pollution, including through strategies on access to clean energies, clean and efficient transport, control of industrial emissions, the sound use of chemicals, as it is a highly cost- effective strategy for enhancing population health, reducing the burden on limited health resources and advancing national development;
2023/07/24
Committee: DEVE